Myocardial Infarction

Results of RIBS IV trial reported

A new clinical trial comparing the use of everolimus-eluting stents (EES) and drug-eluting balloons (DEB) in treating in-stent restenosis (ISR) from drug-eluting stents found that EES provided superior late angiographic results ...

Sep 16, 2014
popularity 2 / 5 (1) | comments 0

Results of DKCRUSH-VI trial reported

A new study found that fractional flow reserve (FFR)-guided provisional side branch (SB) stenting of true coronary bifurcation lesions yields similar outcomes to the current standard of care. The DKCRUSH-VI clinical trial ...

Sep 16, 2014
popularity 3.5 / 5 (2) | comments 0

Results of IVUS-CTO trial reported at TCT 2014

A new study found that intravascular ultrasound (IVUS) -guided intervention in patients with chronic total occlusion (CTO) could improve outcomes compared to a conventional angiography-guided approach during percutaneous ...

Sep 16, 2014
popularity not rated yet | comments 0

Results of OCT STEMI trial reported at TCT 2014

The first randomized trial to examine serial optical coherence tomography (OCT) in primary percutaneous coronary intervention (PCI) was reported at the 26th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific ...

Sep 16, 2014
popularity not rated yet | comments 0

Hopes dashed for an agent to prevent reperfusion injury

The administration of an experimental agent known as TRO40303 to patients who have had a heart attack, with the hope of preventing tissue damage when impaired blood flow is corrected (reperfusion), was disappointingly ineffective ...

Sep 02, 2014
popularity not rated yet | comments 0

Polypill increases adherence to post MI treatment

A new polypill increases adherence to treatment following a myocardial infarction (MI), according to results from the FOCUS Study presented for the first time at ESC Congress 2014 today by principal investigator ...

Sep 02, 2014
popularity not rated yet | comments 0

Latest Spotlight News

New compounds reduce debilitating inflammation

Six Case Western Reserve scientists are part of an international team that has discovered two compounds that show promise in decreasing inflammation associated with diseases such as ulcerative colitis, arthritis and multiple ...